- Report
- March 2025
- 227 Pages
Global
From €2203EUR$2,500USD£1,935GBP
- Report
- December 2025
United States
From €3516EUR$3,990USD£3,088GBP
- Report
- December 2025
Europe
From €3516EUR$3,990USD£3,088GBP
- Report
- December 2025
Middle East
From €3516EUR$3,990USD£3,088GBP
- Report
- December 2025
Asia Pacific
From €3516EUR$3,990USD£3,088GBP
- Report
- August 2025
- 185 Pages
Global
From €3124EUR$3,545USD£2,744GBP
€3471EUR$3,939USD£3,049GBP
- Report
- December 2025
- 268 Pages
Global
From €4803EUR$5,450USD£4,218GBP
- Report
- April 2025
- 250 Pages
Global
From €3957EUR$4,490USD£3,475GBP
- Report
- November 2025
- 160 Pages
Global
From €2959EUR$3,358USD£2,599GBP
€3481EUR$3,950USD£3,057GBP
- Report
- April 2023
- 120 Pages
Global
From €4186EUR$4,750USD£3,677GBP
- Report
- December 2025
China
From €3516EUR$3,990USD£3,088GBP
- Report
- December 2025
United Kingdom
From €3516EUR$3,990USD£3,088GBP
- Report
- December 2025
Global
From €3516EUR$3,990USD£3,088GBP
- Report
- December 2025
North America
From €3516EUR$3,990USD£3,088GBP
- Report
- December 2025
Europe
From €1846EUR$2,095USD£1,622GBP
€3516EUR$3,990USD£3,088GBP
The Blood Grouping Reagent market is a subset of the Blood Banking industry. It is composed of products used to identify the ABO and Rh blood group of a patient. These reagents are used to determine the compatibility of a patient's blood with a potential donor's blood, and are essential for successful transfusions. The market is composed of a variety of reagents, including monoclonal and polyclonal antibodies, lectins, and enzymes. These reagents are used in a variety of tests, such as agglutination, precipitation, and ELISA.
The Blood Grouping Reagent market is highly competitive, with a number of companies offering a wide range of products. Some of the major players in the market include Immucor, Grifols, Ortho Clinical Diagnostics, Bio-Rad Laboratories, and DiaMed. Show Less Read more
